Very interesting post.
I could not get to the full text or at least to the References section.
The abstract mentions two clinical trials:
1).A recent pilot clinical trial assessing the effects of ALA-rich dietary flaxseed on tumor biological markers in postmenopausal patients with primary breast cancer demonstrated significant reductions in tumor growth and in HER2 (erbB-2) oncogene expression.
2).Our results molecularly support a recent randomized double-blind placebo-controlled clinical trial suggesting that ALA may be a potential dietary alternative or adjunct to currently used drugs in the management of HER2-positive breast carcinomas
I assume the first reference is to the 2005 study of the daily intake of a muffin with 25g of ground flaxseeds for a short period before primary tumor surgery.
Can someone recall the details of the second one?
|